I. Gurieva

Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy

U. Munzel, P. Dyck, P. Low, 2006, Diabetes Care.

Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy

D. Ziegler, K. Sommerville, R. Freynhagen, 2010, Diabetes Care.

Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations.

R. Freeman, T. Tankova, S. Tesfaye, 2021, Diabetes research and clinical practice.

Diagnosis and rational treatment of painful diabetic peripheral neuropathy: an interdisciplinary expert consensus

I. Strokov, M. Shestakova, M. Churyukanov, 2019, Diabetes mellitus.

Treatment of Symptomatic Polyneuropathy With Actovegin in Type 2 Diabetic Patients

I. Strokov, D. Ziegler, B. Mankovsky, 2009, Diabetes Care.

Predictors of response to treatment with actovegin for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy.

I. Strokov, D. Ziegler, N. Papanas, 2017, Journal of diabetes and its complications.

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Raymond L. Forbes, A. Astrup, F. Greenway, 2017, The Lancet.

Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy

D. Ziegler, K. Sommerville, R. Freynhagen, 2010, Diabetes Care.